RT @notiscientifico: #notiziarioscientifico Gli asintomatici di #COVIDー19 subiscono comunque delle conseguenze: circa i due terzi dei pazi…
@EdwardGoldste16 @mlipsitch @mugecevik Agree there appears to be big diff in Geneva (but be careful of high % indeterm - strangely higher in young; b/c of low severity? https://t.co/FIZpIFAW8L). This would erase difference. Don't know why indet so high in
@drvidela @decimononnica @alexmilberg No hay evidencias de inmunidad a priori y si existe un caso no hay forma de establecer quien la tiene. La menor incidencia no implica contagiar menos, no hay q estar enfermo para contagiar. Sobre secuelas si se sabe oc
RT @notiscientifico: #notiziarioscientifico Gli asintomatici di #COVIDー19 subiscono comunque delle conseguenze: circa i due terzi dei pazi…
#notiziarioscientifico Gli asintomatici di #COVIDー19 subiscono comunque delle conseguenze: circa i due terzi dei pazienti avevano dei segni di "ground glass" nei polmoni, un difetto che può portare a suscettibilità alle malattie respiratorie. Fonte: http
@AntoinetteColby @OrHekto @JulienLempereu2 @JonathanMar_180 @Alvisyma @GilbertDeray Vous me demandez des statistiques, je vous en donne. Une autre : https://t.co/spOiNbHUIc
RT @ADejeuville: 2/ @ChanasitJonas Auch wenn Infektionzahlen auf einem höheren Niveau stagnieren und nicht mehr anstiegen würden, bedeutet…
@velumania @swapneilparikh Totally in contradiction with what research suggests. https://t.co/BVhFIPFCBy
@NNormalitat @GidMK Re: "How is this possible with around 50% of people having background immunity from T cells." Same answer @GidMK gave you, along with more. https://t.co/JJ3bgpzbXF https://t.co/YzrUHs05ZD https://t.co/A9hcHfOowN
RT @alinerosa29: https://t.co/j89RafVN42. Foi publicado na revista Nature Medicine, que o sistema imunitário do corpo humano não é capaz de…
@nickmusings Context does matter, so sitting next to grandpa in your house is very different than outside. But re asymptomatic spread, start here (and I can provide more sci literature that also documents the extent of asymptomatic spread): https://t.co/9
#news #medical 🔬🏥📚🥼 #virus #evolucion Evaluación clínica e inmunológica de infecciones asintomáticas por SARS-CoV-2 https://t.co/gw2zqKnv3z
2/ @ChanasitJonas Auch wenn Infektionzahlen auf einem höheren Niveau stagnieren und nicht mehr anstiegen würden, bedeutet dies mehr Todesfälle und mehr Patienten mit Langzeitfolgen (keine Einzelfälle): https://t.co/O6IaIzDGP6 https://t.co/81QjY2hGOo htt
RT @DNA_PAPA: 新型コロナの無症状感染者の詳細な情報の論文が出ました。59%で肺に異常。まじか。ウイルスまき散らす期間が長い。
RT @DNA_PAPA: 新型コロナの無症状感染者の詳細な情報の論文が出ました。59%で肺に異常。まじか。ウイルスまき散らす期間が長い。
@pmayado No cabe duda que su opinión es de barra de bar. Un poquito de ciencia: https://t.co/TS0Dxefdeo Asymptomatic individuals can spread the virus efficiently, and the emergence of these silent spreaders of SARS-CoV-2 has caused difficulties in the c
@Angelisimo2 @C19Roberto @Fer137xyz @gonzo_blogger Hablemos de asintomáticos: https://t.co/TS0Dxefdeo
RT @NADJA60753506: 無症状患者の59%肺に異常有 インフルエンザでも風邪でもない 誰にも解明されていない恐るべきウイルスです
RT @doctormacias: Covid19, buena noticia. Mucha gente que pareciera susceptible al virus no lo es, quizás porque tiene inmunidad cruzada co…
'The median duration of viral shedding in the asymptomatic group was 19 d[ays]. The asymptomatic group had a significantly longer duration of viral shedding than the symptomatic group' So asymptomatic-infected people are just casually infecting everyone.
https://t.co/j89RafVN42. Foi publicado na revista Nature Medicine, que o sistema imunitário do corpo humano não é capaz de criar resistência contra o SARS-CoV-2,em três meses o corpo pode não reconhecer mais o vírus,e que necessitariamos de reforço de temp
RT @JuanGrvas: #SARSCoV2 40% of asymptomatic individuals became seronegative and 12.9% of the symptomatic group became negative for IgG in…
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections | Nature Medicine https://t.co/Lniq5CfYXN
@jdshutt There are a bunch of theories why this might be, but one of the most hopeful is the idea of t-cell mediated cross immunity with other coronviruses being widespread: https://t.co/FtaZ4azUx0 https://t.co/G6ENTrBxXc https://t.co/OqdxluKxNK
Recomendado de hoy #Covid_19 https://t.co/dVOVQT7VEb “Eight weeks after recovery, antibody levels fell to undetectable levels in 40% of asymptomatic people and 13% of symptomatic people” Amanecerá y veremos.
#SARSCoV2 40% of asymptomatic individuals became seronegative and 12.9% of the symptomatic group became negative for IgG in the early convalescent phase. Pérdida de inmunidad precoz en 40% pacientes asintomáticos y 12,9% sintomáticos. https://t.co/HtAHa65I
・無症状患者は抗体レベルが弱い(サイトカインレベルからも明らか) ・過去に広まったSARS-CoVやMERS-CoVでは、抗体は2年以上保持されたが、今回のSARS-CoV-2の抗体は2~3ヵ月で減少に転じてしまう Nature MedicineのURLを貼ります。この論文は全文公開です。 (続く) #COVID19 https://t.co/4Kl4NkPoYf
「無症状のコロナウイルス肺炎」について。Topol先生が紹介してる論文が重要に思います。 ・PCR陽性でも無症状の60人を抽出。隔離中に次々と発症して除外。最終的に37人を無症状として分析。 ・発症者よりも無症状の方が長くウイルスを排出する ・無症状でも胸部CTでは肺炎の所見有り (続く) #COVID19
RT @sankar_mm: Detected high levels of IgG and Neutralizing Antibodies of SARS-COV-2 infected individuals. @ICMRDELHI @BIRAC_2012 @SerumIns…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
Detected high levels of IgG and Neutralizing Antibodies of SARS-COV-2 infected individuals. @ICMRDELHI @BIRAC_2012 @SerumInstIndia @BharatBiotech @ZydusUniverse #SeroSurvey #immunitypasspot #HerdImmunity
RT @DNA_PAPA: 新型コロナの無症状感染者の詳細な情報の論文が出ました。59%で肺に異常。まじか。ウイルスまき散らす期間が長い。
RT @DNA_PAPA: 新型コロナの無症状感染者の詳細な情報の論文が出ました。59%で肺に異常。まじか。ウイルスまき散らす期間が長い。
@florian_krammer It must be a huge conspiracy that both NEJM and Nature are in on! https://t.co/bxbKlCYr8v
RT @EricTopol: 3. So many studies have reported IgG, IgM but provide no insight on T-cell mediated immunity, no less serially assess this o…
RT @nanogenomic: Asymptomatic patients are producing fewer IgG antibodies than symptomatic. “The virus-specific IgG levels in the asympto…
Last month, a study published in Nature Medicine delivered what seemed like bad news: Antibodies to the coronavirus may start to fade within just two to three months. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections #Covid_19
RT @nanogenomic: Asymptomatic patients are producing fewer IgG antibodies than symptomatic. “The virus-specific IgG levels in the asympto…
@opmarburg „Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections“ https://t.co/PaSXGma5JQ
Asymptomatic patients are producing fewer IgG antibodies than symptomatic. “The virus-specific IgG levels in the asymptomatic group... were significantly lower... relative to the symptomatic group... in the acute phase.” https://t.co/J768OKFSfJ
RT @DNA_PAPA: 新型コロナの無症状感染者の詳細な情報の論文が出ました。59%で肺に異常。まじか。ウイルスまき散らす期間が長い。 https://t.co/gEzschoUqC
@jordanalipscomb @Amy_Siskind Viral shedding in some people can last an between 6 and 45 days. It seems he is still contagious/shedding virus. https://t.co/wwCiZAeoJ1
@XavierHugonet @Fraslin https://t.co/h1j4ktQ7X9 "The reduction in IgG and neutralizing antibody levels in the early convalescent phase might have implications for immunity strategy and serological surveys."
Asymptomatic individuals with #COVID19 have a longer duration of viral shedding than those who’re symptomatic; they also have lower levels of virus-specific IgG antibodies & show rapid reduction earlier in the acute phase of infection👉 https://t.co/oI
@AnnetteBruchfe1 Interesting, thanks for sharing. Somewhat different than this June @NatureMedicine paper that was discussed a lot earlier: They find a larger percentage exhibiting reduction in #neutralizing #antibody levels in #asymptomatic vs symptomati
RT @EricTopol: 3. So many studies have reported IgG, IgM but provide no insight on T-cell mediated immunity, no less serially assess this o…
@GturuleCAT @Angelisimo2 @Estrell657 Qué pena que maneje un estudio con poca muestra: 1 Le paso uno más amplio y moderno: https://t.co/TS0Dxefdeo
@Damian_Roy @isabelrodbar Re: "Just quoting yourself there?" You see the underlined words there? Those are links to papers supporting each point I said. Your talking points are not new, so I have responses prepared already. Re: "It's in the T-cells" Try
@JudgeClayJ Read data collection section: https://t.co/cQEI9mce2S
RT @RaulWilliems: @RutlandRex @mrsamman019 @DrEricDing Breathing is enough, singing and shouting very good too. Viral load greater without…
@SteveOStereo @UNMC_DrKhan @V2019N @Surgeon_General @drsanjaygupta @CDCDirector @SecAzar And another very recent one. The initial German publish was attacked because the official might have used the wrong words with asymptomatic vs pre-symptomatic but the
@realdb2 @aldanibcn @CovidSerology @BriongloidBoy @jdevans141 @isabelrodbar @MLevitt_NP2013 Re: "People are conflating T-cell resistance with complete antibody supported immunity. What's being discovered now is an unknown % have T-cell resistance. Doesn't
🔗Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections https://t.co/B2HC9drJ7D
Key data to assess asymptomatic cases in the #COVID19 #pandemic https://t.co/JimxA5j2rF
@Calla16529089 @C_Althaus Re: "What about this?" https://t.co/JJ3bgphAz5
@BrocqChristine @MartinTurnbul19 @marcformarc @moby_dickhead If I'm not mistaken, last month there was a study showing the antibodies lasts only around 2 - 3 months only. Here's the link, you can scroll straight to the Discussion area. https://t.co/bQEeuhw
@duniamanji org2 ga bergejala justru krn imun lemah! Imun kuat/berlebihan malah reaksi parah, jd hyper saat covid nyerang mknya diksh immunosuppressant https://t.co/cpyFzb92p1 These data suggest that asymptomatic individuals had a weaker immune response t
Asymptomatic patients have -a significantly longer duration of viral shedding than the symptomatic group -had a weaker immune response to SARS-CoV-2 infection Implications for immunity strategy?! https://t.co/a253NpuFyf https://t.co/hMNfCVSR9f
[4/n] But, the most relevant source of error is the dynamics of the immune response. Nature paper suggests that antibody levels fade quickly. https://t.co/iXcZ7c5cRJ
@BioHospitalix Hypothèse de l'immunité cellulaire ? parce qu'il semble que l'humorale ne tienne pas du tout la route à long terme, avec 3 à 6 mois de tenue des Ac il va être compliqué d'obtenir une immu collective uniquement avec celle ci. https://t.co/Hr1
Don’t assume you'll have automatic #immunity, if you’ve recovered from #COVID. It’s unclear just how long those COVID antibodies will last, so it’s important to still follow the golden rules: wash hands often, wear a mask & sanitize https://t.co/zSDNBi
@nuriadelamo1 Creo que era este. Compararon asintomáticos con casos graves y el resultado de pérdida de AC era mayor en los asintomáticos con duraciones de entre dos y tres meses. https://t.co/AQz2z1n1DY
RT @SQ300: @suzuki_takaya PCR検査でのCt値(ウイルス量を反映)によって治療方針の絞り込みや予後の予測ができればよいですが、なかなかそう簡単にはいかないのではないかと思います。 重慶の病院からの報告(Nat Med)によれば https://t.c…
RT @VincentRK: 1) We have data that almost half the persons with PCR positive COVID who are asymptomatic or found by screening studies can…
RT @VincentRK: 1) We have data that almost half the persons with PCR positive COVID who are asymptomatic or found by screening studies can…
RT @DNA_PAPA: 新型コロナの無症状感染者の詳細な情報の論文が出ました。59%で肺に異常。まじか。ウイルスまき散らす期間が長い。
RT @NADJA60753506: 無症状患者の59%肺に異常有 インフルエンザでも風邪でもない 誰にも解明されていない恐るべきウイルスです
RT @VincentRK: 1) We have data that almost half the persons with PCR positive COVID who are asymptomatic or found by screening studies can…
RT @VincentRK: 1) We have data that almost half the persons with PCR positive COVID who are asymptomatic or found by screening studies can…
RT @VincentRK: 1) We have data that almost half the persons with PCR positive COVID who are asymptomatic or found by screening studies can…
RT @NADJA60753506: 無症状患者の59%肺に異常有 インフルエンザでも風邪でもない 誰にも解明されていない恐るべきウイルスです
@MichaelYeadon3 @mesonparticle @rlmassio @Warnzwifey @GrammaIonas @devillefilm @EmmaKennedy Re: " a substantial fraction (30-50%) of the pop possessed T-memory vs cov-2 before seeing the virus" No, they didn't. Memory, by definition, only comes after prio
RT @SQ300: @suzuki_takaya PCR検査でのCt値(ウイルス量を反映)によって治療方針の絞り込みや予後の予測ができればよいですが、なかなかそう簡単にはいかないのではないかと思います。 重慶の病院からの報告(Nat Med)によれば https://t.c…
@CherylRofer I'd like to see antobody levels a little further out than 43 days from second injection, since observational studies suggest antibody levels drop off significantly somewhere between 4 and 8 weeks. https://t.co/sDrmv47DpW https://t.co/2F12SO95
RT @VincentRK: 1) We have data that almost half the persons with PCR positive COVID who are asymptomatic or found by screening studies can…
RT @VincentRK: One more study @NatureMedicine showing asymptomatic COVID people can become seronegative quickly. Authors warned that they m…
RT @SQ300: @suzuki_takaya PCR検査でのCt値(ウイルス量を反映)によって治療方針の絞り込みや予後の予測ができればよいですが、なかなかそう簡単にはいかないのではないかと思います。 重慶の病院からの報告(Nat Med)によれば https://t.c…
@suzuki_takaya PCR検査でのCt値(ウイルス量を反映)によって治療方針の絞り込みや予後の予測ができればよいですが、なかなかそう簡単にはいかないのではないかと思います。 重慶の病院からの報告(Nat Med)によれば https://t.co/t2SD6OsOmV ・PCR陽性、無症状の37人 ・性別年齢などがマッチした有症状37人 の2群 →
RT @VincentRK: 1) We have data that almost half the persons with PCR positive COVID who are asymptomatic or found by screening studies can…
1) We have data that almost half the persons with PCR positive COVID who are asymptomatic or found by screening studies can become sero negative. Becoming sero negative doesn’t automatically mean they are not immune. First this @NatureMedicine study: http
RT @NADJA60753506: 無症状患者の59%肺に異常有 インフルエンザでも風邪でもない 誰にも解明されていない恐るべきウイルスです
More information to help interpret seroconversion in COVID-19 patients: Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections | Nature Medicine https://t.co/qjOrz0EJ12
RT @VincentRK: One more study @NatureMedicine showing asymptomatic COVID people can become seronegative quickly. Authors warned that they m…
One more study @NatureMedicine showing asymptomatic COVID people can become seronegative quickly. Authors warned that they may not be immune. But we have to keep in mind that they very well could be immune & wont be captured in seroprevalence studies.
RT @NADJA60753506: 無症状患者の59%肺に異常有 インフルエンザでも風邪でもない 誰にも解明されていない恐るべきウイルスです https://t.co/DrzLNd3ro0
RT @EricTopol: The first in-depth, dedicated, immunologic profile of people who had #COVID19 but never developed symptoms—the asymptomatics…
RT @DNA_PAPA: 新型コロナの無症状感染者の詳細な情報の論文が出ました。59%で肺に異常。まじか。ウイルスまき散らす期間が長い。